A joint op-ed by NACDS and the Healthcare Distribution Alliance (HDA) was published in The Hill today on the inherent risks of importing drugs from foreign markets. The op-ed noted that importation threatens the progress the industry and the government have made in collaborating to secure the safety of the domestic pharmaceutical supply chain and would undo all the hard work that has been accomplished since the enactment of the landmark Drug Supply Chain Security Act four years ago. NACDS and HDA also urged the Senate Committee on Health, Education, Labor and Pensions and other members of Congress to protect patients and the safety of the supply chain, stating: “We, and ultimately the patients we serve, simply cannot afford to risk the entrance of substandard, unsafe medicines into one of the safest and strongest supply chains in the world.”
